The mean number of VUS for MMR genes (MLH1, MSH2, MSH6 and PMS2) was significantly higher in the pancreatic cancer group (cancer patient, 0.13 vs. control, 0.04; P = 0.033) than that in the control group. This evidence concerns the gene MLH1 and pancreatic neoplasm.